Combined microwave ablation and systemic chemotherapy for liver metastases from oesophageal cancer: Preliminary results and literature review

References

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86.
   PubMed Web of Science ®Google Scholar
• Feng XS, Yang YT, Gao SG, Ru Y, Wang GP, Zhou B, et al. Prevalence and age, gender and geographical area distribution of esophageal squamous cell carcinomas in North China from 1985 to 2006. Asian Pac J Cancer Prev 2014;15:1981–7.
   PubMedGoogle Scholar
• Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med 2014;371:2499–509.
   PubMed Web of Science ®Google Scholar
• Huddy JR, Thomas RL, Worthington TR, Karanjia ND. Liver metastases from esophageal carcinoma: is there a role for surgical resection? Dis Esophagus 2015;28: 483–7.
   PubMed Web of Science ®Google Scholar
• Ichida H, Imamura H, Yoshimoto J, Sugo H, Kajiyama Y, Tsurumaru M, et al. Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma. World J Surg 2013;37:398–407.
   PubMed Web of Science ®Google Scholar
• Hsu PK, Wang BY, Huang CS, Wu YC, Hsu WH. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg 2011;15:558–65.
   PubMed Web of Science ®Google Scholar
• Choti MA. Liver-directed treatments for metastatic colorectal cancer. Curr Treat Options Oncol 2014;15:456–64.
   PubMed Web of Science ®Google Scholar
• Hironaka S, Tsubosa Y, Mizusawa J, Hironaka S, Tsubosa Y, Mizusawa J, et al. Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807). Cancer Sci 2014;105:1189–95.
   PubMed Web of Science ®Google Scholar
• Wang J, Chang J, Yu H, Wu X,Wang H, Li W, et al. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus. Cancer Chemother Pharmacol 2013;71:905–11.
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology 2009;251:933–40.
   PubMed Web of Science ®Google Scholar
• Wang J, Liang P, Yu J, Yu MA, Liu F, Cheng Z, et al. Clinical outcome of ultrasound-guided percutaneous microwave ablation on colorectal liver metastases. Oncol Lett 2014;8:323–26.
   PubMed Web of Science ®Google Scholar
• Liang P, Dong B, Yu X, Yu D, Cheng Z, Su L, et al. Computer-aided dynamic simulation of microwave-induced thermal distribution in coagulation of liver cancer. IEEE Trans Biomed Eng 2001;48:821–9.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. J Vasc Interv Radiol 2014;25:1691–705.
   PubMed Web of Science ®Google Scholar
• Iitaka D, Shiozaki A, Fujiwara H, Ichikawa D, Okamoto K, Komatsu S, et al. Case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case. Surg Today 2013;43:556–61.
   PubMed Web of Science ®Google Scholar
• Mohamed A, El-Rayes B, Khuri FR, Saba NF. Targeted therapies in metastatic esophageal cancer: advances over the past decade. Crit Rev Oncol Hematol 2014;91:186–96.
   PubMed Web of Science ®Google Scholar
• Mudan SS, Giakoustidis A, Giakoustidis D, Slevin M. Synchronous oesophagectomy and hepatic resection for metastatic oesophageal cancer: report of a case. Hippokratia 2010;14:291–3.
   PubMed Web of Science ®Google Scholar
• Andreou A, Viganò L, Zimmitti G, Seehofer D, Dreyer M, Pascher A, et al. Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer. J Gastrointest Surg 2014;18:1974–86.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S. Conformal radiation therapy for liver metastasis of esophageal carcinoma. Hepatogastroenterology 2003;50:532–4.
   PubMed Web of Science ®Google Scholar
• Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, et al. A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 2004;15:955–9.
   PubMed Web of Science ®Google Scholar
• Uchikado Y, Natsugoe S, Okumura H, Matsumoto M, Setoyama T, Takigawa J, et al. A case of successful treatment by low-dose 5-fluorouracil and cisplatin for liver metastases of esophageal adenosquamous carcinoma. Gan To Kagaku Ryoho 2006;33:83–5.
   PubMedGoogle Scholar
• Nakajima Y, Nagai K, Kawano T, Inoue H, Nara S, Kumagai Y, et al. Therapeutic strategy for postoperative liver metastasis from esophageal squamous cell carcinoma; clinical efficacy of and problem with hepatic arterial infusion chemotherapy. Hepatogastroenterology 2001;48:1652–5.
   PubMed Web of Science ®Google Scholar
• Toh U, Sudo T, Kido K, Tanaka T, Sueyoshi S, Fujita H, et al. Intraarterial cellular immunotherapy for patients with inoperable liver metastases of esophageal cancer. Gan To Kagaku Ryoho 2002;29:2152–6.
   PubMedGoogle Scholar
• Iwahashi M, Tanimura H, Nakamori M, Nagai Y, Hirabayashi N, Ueda K, et al. Clinical evaluation of hepatic arterial infusion of low dose-CDDP and 5-FU with hyperthermotherapy: a preliminary study for liver metastases from esophageal and gastric cancer. Hepatogastroenterology 1999;46:2504–10.
   PubMed Web of Science ®Google Scholar
• Nagano H, Sakon M, Yasuda T, Dono K, Nakamori S, Yano M, et al. A case of postoperative multiple hepatic metastasis from esophageal cancer successfully treated by surgical resection and hepatic arterial infusion chemotherapy. Gan To Kagaku Ryoho 2001;28:1628–31.
   PubMedGoogle Scholar
• Wada N, Yamasaki M, Hayashi T, Miyata H, Takahashi T, Kurokawa Y, et al. Clinical experience of topical treatments for liver metastases from esophageal carcinoma. Gan To Kagaku Ryoho 2013;40:2158–60.
   PubMedGoogle Scholar
• Egawa T, Okubo Y, Kemmochi T, Mori T, Sato S, Nishiya S, et al. A case of liver metastasis from esophageal cancer treated with stereotactic body radiation therapy. Gan To Kagaku Ryoho 2013;40:1850–2.
   PubMedGoogle Scholar
• Ikebe M, Kitamura M, Saitoh G, Hasegawa H. Multimodality therapy containing hepatic arterial infusion chemotherapy for liver metastasis of esophageal cancer – a case report. Gan To Kagaku Ryoho 2012;39:1555–7.
   PubMedGoogle Scholar
• Shuto K, Ohira G, Kono T, Natsume T, Tohma T, Sato A, et al. Regional treatment of esophageal liver metastasis by intra-arterial low-dose 5-FU therapy. Gan To Kagaku Ryoho 2010;37:2409–11.
   PubMedGoogle Scholar
• Kubota H, Matsumoto H, Saito A, Kaida Y, Murakami H, Higashida M, et al. A case of chemo-radiation therapy with high degree of efficacy for esophageal cancer with liver metastasis. Gan To Kagaku Ryoho 2009;36:2045–8.
   PubMedGoogle Scholar
• Li M, Yu X, Liang P, Dong B, Liu F. Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperthermia 2015;31:579–87.
   PubMed Web of Science ®Google Scholar
• Zhang D, Xie D, Wei X, Zhang D, Chen M, Yu X, et al. Microwave ablation of the liver abutting the stomach: insulating effect of a chitosan-based thermosensitive hydrogel. Int J Hyperthermia 2014;30:126–33
   PubMed Web of Science ®Google Scholar
• Zhang D, Liang P, Yu X, Cheng Z, Han Z, Yu J, et al. The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study. Int J Hyperthermia 2013;29:663–70.
   PubMed Web of Science ®Google Scholar
• Li M, Yu XL, Liang P, Liu F, Dong B, Zhou P. Percutaneous microwave ablation for liver cancer adjacent to the diaphragm. Int J Hyperthermia 2012;28:218–26.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang Y, Yu X, Dong B, Zhou P, Ren H, et al. Is percutaneous microwave ablation of liver tumor safe for patients with renal dysfunction. Eur J Radiol 2011;79:e103–7.
   PubMed Web of Science ®Google Scholar